2020 연구자 정보 (12 / 991)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Fujikawa, Hiroyuki
(Fujikawa, H)


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients SCIE 1.5 ONCOLOGY
Hiro, Junichiro
(Hiro, J)


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients SCIE 1.5 ONCOLOGY
Hong, Kyung Soo
(Hong, KS)
Sungkyunkwan Univ SKKU, SKKU Inst Convergence, Dept Biomed Engn, Suwon, South Korea
Yeungnam Univ, Coll Med, Dept Internal Med, Div Pulmonol & Allergy, Daegu 42415, South Korea
Yeungnam Univ, Med Ctr, Reg Ctr Resp Dis, Daegu 42415, South Korea


[JCR상위 1.5%] COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
[JCR상위 4.3%] Ferritin Nanocage-Based Methyltransferase SETD6 for COVID-19 Therapy
SCIE 1.5 BIOCHEMISTRY & MOLECULAR BIOLOGY
CELL BIOLOGY
CHEMISTRY, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL
MATERIALS SCIENCE, MULTIDISCIPLINARY
NANOSCIENCE & NANOTECHNOLOGY
PHYSICS, APPLIED
PHYSICS, CONDENSED MATTER
letact@yu.ac.kr
baejs@knu.ac.kr
ykseo@kribb.re.kr
jang83@ynu.ac.kr
wonhwalee@kribb.re.kr
Ide, Shozo
(Ide, S)


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients SCIE 1.5 ONCOLOGY
Izumi, Namiki
(Izumi, N)
Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan

[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma
SCIE 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
aalsina@tgmg.org
Jang, Jong Geol
(Jang, JG)
교신저자 Sungkyunkwan Univ SKKU, SKKU Inst Convergence, Dept Biomed Engn, Suwon, South Korea
Yeungnam Univ, Coll Med, Dept Internal Med, Div Pulmonol & Allergy, Daegu 42415, South Korea
Yeungnam Univ, Med Ctr, Reg Ctr Resp Dis, Daegu 42415, South Korea


[JCR상위 1.5%] COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
[JCR상위 4.3%] Ferritin Nanocage-Based Methyltransferase SETD6 for COVID-19 Therapy
SCIE 1.5 BIOCHEMISTRY & MOLECULAR BIOLOGY
CELL BIOLOGY
CHEMISTRY, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL
MATERIALS SCIENCE, MULTIDISCIPLINARY
NANOSCIENCE & NANOTECHNOLOGY
PHYSICS, APPLIED
PHYSICS, CONDENSED MATTER
letact@yu.ac.kr
baejs@knu.ac.kr
ykseo@kribb.re.kr
jang83@ynu.ac.kr
wonhwalee@kribb.re.kr
Kim, Jong Gwang
(Kim, JG)
교신저자 Kyungpook Natl Univ, Canc Res Inst, Dept Oncol Hematol, Chilgok Hosp,Sch Med, 807 Hogukno, Daegu 41404, South Korea
Kyungpook Natl Univ, Sch Med, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea
Kyungpook Natl Univ, Dept Oncol Hematol, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Chilgok Hosp, Daegu, South Korea
JXL-8219-2024
Kim, Sung-Bae

[JCR상위 1.5%] The relationship between tumor-infiltrating lymphocytes, PD-L1 expression, and clinical outcomes of Asian melanoma patients treated with anti-PD-1 antibody.
[JCR상위 1.5%] Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.
[JCR상위 80.4%] Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
[JCR상위 42.4%] High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer
[JCR상위 41.5%] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial
[JCR상위 35.6%] Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
[JCR상위 13.4%] Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial ocr
[JCR상위 17.6%] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6%] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
[JCR상위 1.9%] Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial
SCIE 1.5 ONCOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
MEDICINE, GENERAL & INTERNAL
GASTROENTEROLOGY & HEPATOLOGY
jkk21c@knu.ac.kr
keunhur@knu.ac.kr
infection@korea.ac.kr
drwookyun@jnu.ac.kr
bwkang@knu.ac.kr
bwkang@knu.ac.krInkeun
yhk0215@korea.ac.kr
nboku@ncc.go.jp
dcatenac@bsd.uchicago.edu
Kudo, Masatoshi
(Kudo, M)
Kindai Univ, Dept Med, Osaka, Japan AAA-9744-2019
Kudo, Masatoshi
0000-0002-4102-3474
Kudo, Masatoshi
[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 7.1%] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma
SCIE 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
aalsina@tgmg.org
Kusunoki, Masato
(Kusunoki, M)


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients SCIE 1.5 ONCOLOGY
Lee, In Hee
(Lee, IH)
제1저자 Catholic Univ Daegu, Sch Med, Dept Oncol Hematol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea
Daegu Catholic Univ, Dept Internal Med, Div Hematol Oncol, Sch Med, Daegu, South Korea


[JCR상위 1.5%] The relationship between tumor-infiltrating lymphocytes, PD-L1 expression, and clinical outcomes of Asian melanoma patients treated with anti-PD-1 antibody.
[JCR상위 45.3%] Utility of ¹⁸F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
[JCR상위 1.5%] Del-1 and MFG-E8 expression to differentially modulate prognosis of patients with triple-negative breast cancer.
[JCR상위 35.6%] Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
SCIE 1.5 ONCOLOGY
MEDICINE, GENERAL & INTERNAL
yschae@knu.ac.kr
bwkang@knu.ac.kr
bwkang@knu.ac.krInkeun
Lopez, Carlos Lopez
(Lopéz, CL)
ABP-9145-2022
LOPEZ, CARLOS

[JCR상위 1.5%] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC) SCIE 1.5 ONCOLOGY
Moon, Joon Ho
(Moon, JH)
교신저자 Kyungpook Natl Univ, Dept Hematol Oncol, Kyungpook Natl Univ Hosp, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
Kyungpook Natl Univ Hosp, Dept Hematol & Med Oncol, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol & Oncol, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol & Oncol, Daegu, South Korea

0000-0003-3756-796X
Moon, Joon-ho
Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma
[JCR상위 1.5%] Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.
[JCR상위 22.0%] Favorable Long-term Outcomes with Autologous Stem Cell Transplantation for High Risk Patients with Multiple Myeloma Who are Positive at FDG-PET/CT
[JCR상위 29.3%] COVID-19 transmission and blood transfusion: A case report
[JCR상위 65.1%] Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation
[JCR상위 22.9%] RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
[JCR상위 45.4%] Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019)
[JCR상위 23.1%] Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia
[JCR상위 50.7%] Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis
[JCR상위 36.2%] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
ESCI
SCIE
1.5 HEMATOLOGY
ONCOLOGY
IMMUNOLOGY
TRANSPLANTATION
INFECTIOUS DISEASES
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
MULTIDISCIPLINARY SCIENCES
MEDICINE, GENERAL & INTERNAL
jhmoon@knu.ac.kr
baekdw83@gmail.com
sksohn@knu.ac.kr
hjoonk@chonnam.ac.kr
zhaolei.zhang@utoronto.ca
dr.dennis.kim@uhn.ca
hemakim@yuhs.ac
jaminbyun@naver.com
alertjun@hanmail.net
doh@cha.ac.kr
yhimhy@naver.com
dyr1160@dsmc.or.kr
jspark65@ajou.ac.kr
chulwonl.jung@samsung.com
drydh1685@hotmail.com
jhwon.sch@gmail.com
mlee@kuh.ac.kr
jhmoon74@naver.com
yeungchul@ewha.ac.kr
deogyeon@cnu.ac.kr
jchriste@naver.com
jhlee3@amc.seoul.kr
jhlee@gilhospital.com
junglim3@gmail.com
ssysmc@snu.ac.kr
drjejung@chonnam.ac.kr
HEMAKIM@yuhs.ac
Ohi, Masaki
(Ohi, M)


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients SCIE 1.5 ONCOLOGY
Okugawa, Yoshinaga
(Okugawa, Y)
제1저자 Baylor Univ, Med Ctr, Baylor Scott & White Hlth Res Inst, Ctr Gastrointestinal Res, Dallas, TX USA
Baylor Univ, Med Ctr, Baylor Scott & White Hlth Res Inst, Ctr Translat Genom & Oncol, Dallas, TX USA
Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA


[JCR상위 1.5%] Circulating miR-203 secreted from metastatic tissues could exacerbate myopenia in colorectal cancer patients
[JCR상위 2.7%] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer
SCIE 1.5 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
glopez@mdanderson.org
gcalin@mdanderson.org
Park, Chun Gwon
(Park, CG)
Sungkyunkwan Univ SKKU, SKKU Inst Convergence, Dept Biomed Engn, Suwon, South Korea
Sungkyunkwan Univ, Biomed Inst Convergence, SKKU BICS, 2066 Seobu Ro, Suwon 16419, South Korea

0000-0002-8926-3418
Park, Chun Gwon
[JCR상위 1.5%] COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm SCIE 1.5 BIOCHEMISTRY & MOLECULAR BIOLOGY
CELL BIOLOGY
letact@yu.ac.kr
baejs@knu.ac.kr
ykseo@kribb.re.kr
페이지 이동: